- Home
- Publications
- Publication Search
- Publication Details
Title
Boosting immune system against cancer by resveratrol
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-06-09
DOI
10.1002/ptr.7189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells
- (2021) Mengmeng Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- NK cell-based cancer immunotherapy: from basic biology to clinical development
- (2021) Sizhe Liu et al. Journal of Hematology & Oncology
- Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes
- (2021) Alfie T. Baker et al. JOURNAL OF IMMUNOLOGY
- Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway
- (2021) Bikash Chandra Jena et al. BIOCHEMICAL PHARMACOLOGY
- The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment
- (2020) Andreas Bikfalvi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Tumor Microenvironment
- (2020) Borros Arneth Medicina-Lithuania
- TGF-β in radiotherapy: mechanisms of tumor resistance and normal tissues injury
- (2020) Bagher Farhood et al. PHARMACOLOGICAL RESEARCH
- Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis
- (2020) Ana C. Martins Cavaco et al. CANCER AND METASTASIS REVIEWS
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Resveratrol induces apoptosis and attenuates proliferation of MCF-7 cells in combination with radiation and hyperthermia.
- (2020) Peyman Amini et al. CURRENT MOLECULAR MEDICINE
- Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets
- (2020) Rosamaria Lappano et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Inducers, Attractors and Modulators of CD4+ Treg Cells in Non-Small-Cell Lung Cancer
- (2020) Mengxiao Xie et al. Frontiers in Immunology
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Abscopal effect in radioimmunotherapy
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review
- (2020) Milad Ashrafizadeh et al. PHYTOTHERAPY RESEARCH
- A survey of herbal medicines as tumor microenvironment‐modulating agents
- (2020) Chan‐Ran Park et al. PHYTOTHERAPY RESEARCH
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
- (2020) Reem Saleh et al. CANCER LETTERS
- Damage-associated molecular patterns in tumor radiotherapy
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dendritic cell biology and its role in tumor immunotherapy
- (2020) Yingying Wang et al. Journal of Hematology & Oncology
- PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
- (2020) Milad Ashrafizadeh et al. LIFE SCIENCES
- MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
- (2020) Milad Ashrafizadeh et al. LIFE SCIENCES
- Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
- (2020) Wamidh H. Talib et al. MOLECULES
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities
- (2020) Patrick Freeman et al. Cancers
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives
- (2020) Keywan Mortezaee et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
- (2020) Sundee Dees et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating Natural Killer Cells
- (2020) Beatriz Cózar et al. Cancer Discovery
- TGF-β Mediated Immune Evasion in Cancer—Spotlight on Cancer-Associated Fibroblasts
- (2020) Parisa Ghahremanifard et al. Cancers
- Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
- (2020) Ying Yang et al. Cancers
- Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
- (2020) Milad Ashrafizadeh et al. CELLULAR SIGNALLING
- Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells
- (2019) Chia-Cheng Lin et al. Journal of Dental Sciences
- NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity
- (2019) Keywan Mortezaee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A systematic review of radiation-induced testicular toxicities following radiotherapy for prostate cancer
- (2019) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Influence of Resveratrol on the Immune Response
- (2019) Malaguarnera Nutrients
- Cancer stem cells: A review from origin to therapeutic implications
- (2019) Mohammad Reza Atashzar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Natural compounds as potential adjuvants to cancer therapy: preclinical evidence
- (2019) Shian‐Ren Lin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance
- (2019) Masoud Najafi et al. LIFE SCIENCES
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Resveratrol as an adjuvant for normal tissues protection and tumor sensitization
- (2019) Keywan Mortezaee et al. CURRENT CANCER DRUG TARGETS
- Promising approaches in cancer immunotherapy
- (2019) Nima Taefehshokr et al. IMMUNOBIOLOGY
- Targets for improving tumor response to radiotherapy
- (2019) Keywan Mortezaee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
- (2019) Xu Lei et al. CANCER LETTERS
- Boosting immune system against cancer by melatonin: A mechanistic viewpoint
- (2019) Keywan Mortezaee et al. LIFE SCIENCES
- Stromal reprogramming: A target for tumor therapy
- (2019) Masoud Najafi et al. LIFE SCIENCES
- Harnessing NK Cells for Cancer Treatment
- (2019) Paola Minetto et al. Frontiers in Immunology
- Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk
- (2018) Jinyoung Suh et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells
- (2018) Suyanee Thongchot et al. CANCER LETTERS
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Cancer-associated fibroblasts: Secretions, interactions, and therapy
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
- (2018) Jean-David Fumet et al. BRITISH JOURNAL OF CANCER
- Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches
- (2018) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Is Resveratrol a Cancer Immunomodulatory Molecule?
- (2018) Ly Quoc Trung et al. Frontiers in Pharmacology
- CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
- (2018) Monika C. Brunner-Weinzierl et al. Frontiers in Immunology
- Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
- (2018) Chunmei Fu et al. Frontiers in Immunology
- Emerging roles of SIRT1 in fatty liver diseases
- (2017) Ren-Bo Ding et al. International Journal of Biological Sciences
- Resveratrol stimulates the metabolic reprogramming of human CD4+T cells to enhance effector function
- (2017) Marco Craveiro et al. Science Signaling
- Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer
- (2017) Emma Nolan et al. Science Translational Medicine
- CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function
- (2017) Xi Chen et al. Oncotarget
- Resveratrol stimulates the metabolic reprogramming of human CD4+T cells to enhance effector function
- (2017) Marco Craveiro et al. Science Signaling
- Melatonin as an anti-inflammatory agent in radiotherapy
- (2017) M. Najafi et al. INFLAMMOPHARMACOLOGY
- Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
- (2016) K E Richards et al. ONCOGENE
- Resveratrol and cancer: Challenges for clinical translation
- (2015) Chandra K. Singh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol regulates naïve CD 8+T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expression
- (2015) Kyung Tae Noh et al. BMB Reports
- Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
- (2014) Soo Kyung Jeong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
- (2013) Kyung Tae Noh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice
- (2012) Min Ho Jeong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-mediated Diseases
- (2012) Urban Švajger et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- A Possible Role for Perforin and Granzyme B in Resveratrol-Enhanced Radiosensitivity of Prostate Cancer
- (2012) Y. Fang et al. JOURNAL OF ANDROLOGY
- Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells
- (2012) YOO JIN CHOI et al. Experimental and Therapeutic Medicine
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Trans- but Not Cis-Resveratrol Impairs Angiotensin-II-Mediated Vascular Inflammation through Inhibition of NF- B Activation and Peroxisome Proliferator-Activated Receptor- Upregulation
- (2010) C. Rius et al. JOURNAL OF IMMUNOLOGY
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
- (2010) Chuan-Yong Mu et al. MEDICAL ONCOLOGY
- Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells
- (2008) Yoolhee Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started